Basic Information | Post buying leads | Suppliers |
The Loxapine succinate salt with its cas register number is 27833-64-3. It also can be called as Succinic acid 2-chloro-11-(4-methylpiperazin-1-yl)dibenz[b,f][1,4]oxazepine salt and the IUPAC Name about this chemical is butanedioic acid; 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine. It belongs to the following product categories, such as Intermediates, &, Fine, Chemicals, Pharmaceuticals, Antagonists, Dopaminergics, Neurotransmitters and so on.
Physical properties about Loxapine succinate salt are: (1)ACD/LogP: 2.74; (2)ACD/LogD (pH 5.5): 1.12; (3)ACD/LogD (pH 7.4): 2.56; (4)ACD/BCF (pH 5.5): 1.71; (5)ACD/BCF (pH 7.4): 46.67; (6)ACD/KOC (pH 5.5): 17.77; (7)ACD/KOC (pH 7.4): 483.97; (8)#H bond acceptors: 4; (9)#Freely Rotating Bonds: 1; (10)Polar Surface Area: 28.07Å2; (11)Enthalpy of Vaporization: 71.89 kJ/mol; (12)Vapour Pressure: 1.36E-08 mmHg at 25°C.
The Loxapine succinate salt can be used as a D2/D4-Dopamine receptor antagonist and a serotonergic receptor antagonist, it also can be used as a dibenzoxazepine antipsychotic agent.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(O)CCC(=O)O.Clc2ccc1Oc4c(/N=C(\c1c2)N3CCN(C)CC3)cccc4
(2)InChI: InChI=1/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
(3)InChIKey: YQZBAXDVDZTKEQ-UHFFFAOYAL
(4)Std. InChI: InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
(5)Std. InChIKey: YQZBAXDVDZTKEQ-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
women | LDLo | oral | 30mg/kg (30mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: COMA LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA | Clinical Toxicology. Vol. 14, Pg. 181, 1979. |
women | TDLo | oral | 6mg/kg/2D-I (6mg/kg) | BEHAVIORAL: TOXIC PSYCHOSIS | Journal of Clinical Psychiatry. Vol. 44, Pg. 37, 1983. |
women | TDLo | oral | 27mg/kg/9D-I (27mg/kg) | ENDOCRINE: HYPERGLYCEMIA | Journal of Clinical Psychiatry. Vol. 44, Pg. 347, 1983. |